Resistance rates to commonly used antimicrobials among pathogens of both bacteremic and non-bacteremic community-acquired urinary tract infection

Journal of Microbiology, Immunology and Infection

Volumn 37, Issue 3, 2004, Pages 185-191

  Lau, Sheung Mei ^a   Peng, Ming Yieh ^a   Chang, Feng Yee ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Antibacterial agents; Bacteremia; Microbial drug resistance; Urinary tract infection

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; CEFALOTIN; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; LATAMOXEF; NETILMICIN; PIPERACILLIN; TIMENTIN;

ACINETOBACTER BAUMANNII; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CITROBACTER; COMMUNICABLE DISEASE; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; FEMALE; FEVER; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MALE; MORGANELLA MORGANII; NONHUMAN; PROTEUS MIRABILIS; PROVIDENCIA; PSEUDOMONAS AERUGINOSA; SERRATIA MARCESCENS; TAIWAN; URINARY TRACT INFECTION;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIA; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, BACTERIAL; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; URINARY TRACT INFECTIONS;

EID: 3142512419     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Ho M, McDonald LC, Lauderdale TL, Yeh LL, Chen PC, Shiau YR. Surveillance of antibiotics resistance in Taiwan, 1998. J Microbiol Immunol Infect 1999;32:239-49.
2. Ho P, Yuen K, Yam W, Sai-Yin Wong S, Luk W. Changing patterns of susceptibilities of blood, urinary and respiratory pathogens in Hong Kong. J Hosp Infect 1995;31:305-17.
3. Igari J, Shitara M, Shitara M, Shitara M, Yoshimoto K, Hayashi Y. Susceptibilities of uropathogenic bacteria to ampicillin, cefazolin, cefmetazole and gentamicin. Nine-year survey of changing patterns of susceptibilities. Jpn J Antibiot 1990;43:1530-7.
4. Weber G, Riesenberg K, Schlaeffer F, Peled N, Borer A, Yagupsky P. Changing trends in frequency and antimicrobial resistance of urinary pathogens in outpatient clinics and a hospital in southern Israel, 1991-1995. Eur J Clin Microbiol Infect Dis 1997;16:834-8.
5. Korvick JA, Bryan CS, Farber B, Beam TR Jr, Schenfeld L, Muder RR, et al. Prospective observational study of Klebsiella bacteremia in 230 patients: outcome for antibiotic combinations versus monotherapy. Antimicrob Agents Chemother 1992;36:2639-44.
6. Bryan CS, Reynolds KL. Community-acquired bacteremic urinary tract infection: epidemiology and outcome. J Urol 1984;132:490-3.
7. Weinstein MP, Murphy JR, Reller LB, Melvin P, James R, Kenneth A, et al. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults, II: clinical observations with special reference to factors influencing prognosis. Rev Infect Dis 1983;5:54-70.
8. Bishara J, Leibovici L, Huminer D, Drucker M, Samra Z, Konisberger H, et al. Five-year prospective study of bacteraemic urinary tract infection in a single institution. Eur J Clin Microbiol Infect Dis 1997;16:563-7.
9. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. 6th and 7th ed. Approved Standard M2-A7. Wayne, Pennsylvania. National Committee for Clinical Laboratory Standards 1999 and 2000.
10. Lepelletier D, Caroff N, Reynaud A, Richet H. Escherichia coli: epidemiology and analysis of risk factors for infections caused by resistant strains. Clin Infect Dis 1999;29:548-52.
11. Steinke DT, Seaton RA, Phillips G, MacDonald TM, Davey PG. Factors associated with trimethoprim-resistant bacteria isolated from urine samples. J Antimicrob Chemother 1999;43:841-3.
12. Liu YC, Huang WK, Huang TS, Kunin CM. Detection of antimicrobial activity in urine for epidemiologic studies of antibiotic use. J Clin Epidemiol 1999;52:539-45.
13. Allen UD, MacDonald N, Fuite L, Chan F, Stephens D. Risk factors for resistance to "first-line" antimicrobials among urinary tract isolates of Escherichia coli in children. Can Med Assoc J 1999;160:1436-40.
14. Wright SW, Wrenn KD, Haynes M, Hass DW. Prevalence and risk factors for multidrug resistant uropathogens in ED patients. Am J Emerg Med 2000;18:143-6.
15. Arstila T, Huovinen S, Lager K, Lehtonen A, Huovinen P. Positive correlation between the age of patients and the degree of antimicrobial resistance among urinary strains of Escherichia coli. J Infect 1994;29:9-16.
16. Gales AC, Jones RN, Gordon KA, Sader HS, Wike WW, Beach ML, et al. Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: report from the second year of the SENTRY antimicrobial surveillance program (1998). J Antimicrob Chemother 2000;45:295-303.
17. Jones RN, Kugler KC, Pfaller MA, Winokur PL, and the SENTRY surveillance group, North America. Characteristics of pathogens causing urinary tract infections in hospitals in North America: results from the SENTRY antimicrobial surveillance program, 1997. Diag Microbiol Infect Dis 1999;35:55-63.
18. Finkelstein R, Kassis E, Reinhertz G, Gorenstein S, Herman P. Community-acquired urinary tract infection in adults: a hospital viewpoint. J Hosp Infect 1998;38:193-202.
19. Goldstein FW. Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infection in France. Multicenter study group. Eur J Clin Microbiol Infect Dis 2000;19:112-7.
20. Tsukamoto T, Matsukawa M, Sano M, Takahashi S, Hotta H, Itoh N, et al. Biofilm in complicated urinary tract infection. Int J Antimicrob Agents 1999;11:233-9.
21. Gregor R. Do antibiotics clear bladder infections? J Urol 1994;152:865-7.
22. McDonald LC, Chen FJ, Lo HJ, Yin HC, Lu PL, Huang CH, et al. Emergence of reduced susceptibility and resistance to fluoroquinolones in Escherichia coli in Taiwan and contributions of distinct selective pressures. Antimicrob Agents Chemother 2001;45:3084-91.
23. Thomas FE, Jackson RT, Melly MA, Alford RH. Sequential hospital wide outbreaks of resistant Serratia and Klebsiella infections. Arch Intern Med 1977;137:581-4.